Miryam Mebarki

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Journal: Bone marrow transplantation
Published: March 02, 2026

Real-world comparison of COBE2991 and LOVO Med devices for the post-thaw washing of peripheral blood stem cells and donor lymphocyte infusions.

Real-world comparison of COBE2991 and LOVO Med devices for the post-thaw washing of peripheral blood stem cells and donor lymphocyte infusions.

Journal: Cytotherapy
Published: September 09, 2025

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Journal: Bone marrow transplantation
Published: June 20, 2025

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Journal: Bone marrow transplantation
Published: June 20, 2025

The pharmaceutical circuit of Advanced Therapy Medicinal Products-guidelines of the French Society for Oncology Pharmacy.

The pharmaceutical circuit of Advanced Therapy Medicinal Products-guidelines of the French Society for Oncology Pharmacy.

Journal: Cytotherapy
Published: February 24, 2025

Pooling umbilical cord-mesenchymal stromal cells derived from selected multiple donors reduces donor-dependent variability and improves their immunomodulatory properties.

Pooling umbilical cord-mesenchymal stromal cells derived from selected multiple donors reduces donor-dependent variability and improves their immunomodulatory properties.

Journal: Stem cell research & therapy
Published: November 13, 2024

Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia.

Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: March 20, 2024

Understanding the Angiogenic Characteristics of Clinical-Grade Mesenchymal Stromal Cells Isolated from Human Umbilical Cord.

Understanding the Angiogenic Characteristics of Clinical-Grade Mesenchymal Stromal Cells Isolated from Human Umbilical Cord.

Journal: Stem cell reviews and reports
Published: March 06, 2024

Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.

Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.

Journal: Stem cell research & therapy
Published: December 29, 2023

Early predictive factors of failure in autologous CAR T-cell manufacturing and/or efficacy in hematologic malignancies.

Early predictive factors of failure in autologous CAR T-cell manufacturing and/or efficacy in hematologic malignancies.

Journal: Blood advances
Published: October 23, 2023

Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma.

Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma.

Journal: Blood advances
Published: January 13, 2022

Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells.

Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells.

Journal: Haematologica
Published: December 19, 2021
Showing 1-12 of 26

Last Updated: 09/26/2026